IPO Filing Floodgates: Bronchus Technologies, Inc. (LUNG)

By Douglas A. McIntyre Updated Apr 6, 6:22PM EDT · Published Nov 21, 1:11PM EST

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Bronchus Technologies, Inc. filed yesterday for an initial public offering of up to $86.25 million for filing purposes. It has the proposed ticker of "LUNG" on NASDAQ, and the lead underwriters are Lehman Brothers and Bear Stearns, and co-managers are Jefferies and RBC Capital Markets.

Broncus Technologies is a medical technology company focused on developing and commercializing minimally-invasive medical devices for emphysema and other lung diseases.

"We believe our patented treatment method, Airway Bypass, will be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. We also believe that patients with heterogeneous, or localized, emphysema may also benefit from Airway Bypass. Additionally, we believe that several of our products being developed for Airway Bypass may be used in or adapted for the diagnosis and management of other lung diseases, including pulmonary hypertension and lung cancer."

If you wish to join our open email distribution list we often provide more detailed IPO and spin-off coverage. These are frequently lead-ins to our subscriber-based "Special Situation Investing Newsletter" where we cover buyouts, spin-offs, back-door plays into IPO’s, reorganizations, and more.

Jon C. Ogg
November 21, 2007

About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.